Eurobio Scientific SA
PAR:ALERS

Watchlist Manager
Eurobio Scientific SA Logo
Eurobio Scientific SA
PAR:ALERS
Watchlist
Price: 25.45 EUR -1.55% Market Closed
Market Cap: 254.6m EUR
Have any thoughts about
Eurobio Scientific SA?
Write Note

Cash Flow Statement

Cash Flow Statement
Eurobio Scientific SA

Rotate your device to view
Cash Flow Statement
Currency: EUR
Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Operating Cash Flow
Net Income
(4)
(5)
(6)
(7)
(8)
(9)
(9)
(8)
(4)
(8)
(11)
(7)
(6)
(6)
(5)
(6)
(5)
(5)
(6)
(6)
(8)
(8)
(9)
(10)
(6)
(3)
(2)
3
28
73
81
61
47
25
8
5
Depreciation & Amortization
1
0
0
1
1
0
1
1
1
1
1
1
1
0
1
2
2
2
1
2
3
2
3
6
6
6
7
7
7
7
7
7
7
9
12
14
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
(3)
(13)
2
13
2
0
1
0
(2)
Other Non-Cash Items
0
(0)
(0)
(0)
0
0
(0)
(1)
1
1
0
1
(0)
(0)
0
0
(0)
1
1
0
0
1
3
3
1
1
1
1
1
1
1
0
0
(1)
0
1
Change in Working Capital
(1)
0
2
2
(0)
(1)
1
1
(3)
(0)
2
(0)
0
1
(1)
(2)
(1)
(1)
0
1
1
1
1
3
(0)
(5)
(4)
(2)
(17)
(28)
(17)
(4)
7
9
9
8
Cash from Operating Activities
(4)
N/A
(4)
+3%
(4)
+7%
(5)
-34%
(8)
-53%
(10)
-28%
(8)
+21%
(7)
+12%
(6)
+16%
(6)
-3%
(8)
-42%
(6)
+27%
(5)
+20%
(4)
+7%
(5)
-18%
(5)
+7%
(4)
+26%
(3)
+6%
(3)
+22%
(2)
+8%
(4)
-63%
(3)
+17%
(2)
+53%
2
N/A
1
-59%
(1)
N/A
2
N/A
5
+151%
5
+8%
55
+918%
85
+56%
66
-23%
61
-7%
43
-30%
29
-33%
27
-8%
Investing Cash Flow
Capital Expenditures
(0)
(1)
(2)
(1)
(1)
(1)
(1)
(0)
0
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
0
(0)
(0)
(0)
(0)
(4)
(5)
(2)
(2)
(2)
(1)
(2)
(3)
(2)
(2)
(3)
(5)
(4)
Other Items
0
0
0
0
0
0
0
0
(0)
0
0
0
0
(6)
(6)
0
1
0
0
0
(0)
(1)
(7)
(7)
(1)
0
(0)
(3)
(4)
(2)
(2)
(4)
(5)
(139)
(151)
4
Cash from Investing Activities
(0)
N/A
(0)
-79%
(1)
-268%
(1)
+30%
(1)
+38%
(1)
-115%
(1)
+41%
(0)
+51%
(0)
+12%
(0)
+53%
(0)
-29%
(0)
+61%
(0)
+29%
(6)
-11 400%
(6)
-10%
(0)
+97%
(0)
+5%
(0)
-28%
0
N/A
(0)
N/A
(0)
-645%
(1)
-185%
(7)
-616%
(11)
-59%
(6)
+47%
(2)
+74%
(2)
-17%
(4)
-142%
(5)
-6%
(4)
+14%
(4)
-8%
(5)
-27%
(7)
-22%
(142)
-2 019%
(156)
-10%
(0)
+100%
Financing Cash Flow
Net Issuance of Common Stock
8
2
12
13
2
0
8
24
16
1
0
1
2
6
7
2
3
6
4
3
3
2
10
8
(0)
1
4
3
(0)
(0)
(7)
(7)
(11)
(12)
(2)
(3)
Net Issuance of Debt
(1)
13
14
0
(0)
(0)
(7)
(7)
(0)
(0)
(0)
(8)
(7)
1
(1)
(0)
10
6
(5)
(3)
(3)
1
7
8
3
3
(1)
(6)
10
10
(16)
(16)
(5)
96
90
(18)
Other
0
0
0
0
0
0
(1)
0
0
0
0
0
0
1
0
0
0
0
(0)
(0)
(0)
(2)
(4)
(3)
(2)
(2)
(2)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(3)
Cash from Financing Activities
8
N/A
15
+95%
26
+76%
13
-48%
1
-89%
0
-85%
0
-68%
16
+23 229%
17
+7%
1
-94%
(0)
N/A
(7)
-16 575%
(5)
+27%
7
N/A
6
-11%
1
-82%
13
+1 028%
12
-8%
(1)
N/A
0
N/A
0
+7%
1
+1 723%
13
+2 256%
13
-1%
0
-97%
1
+219%
1
-22%
(4)
N/A
8
N/A
7
-6%
(24)
N/A
(24)
+3%
(17)
+30%
82
N/A
86
+5%
(24)
N/A
Change in Cash
Effect of Foreign Exchange Rates
(0)
(0)
(0)
(0)
(0)
0
0
(0)
0
0
(0)
0
0
(0)
(0)
(0)
(0)
0
0
0
0
(0)
(0)
(0)
(0)
0
0
0
(0)
(0)
0
0
0
(0)
(0)
0
Net Change in Cash
3
N/A
10
+223%
21
+101%
7
-65%
(7)
N/A
(10)
-50%
(8)
+23%
9
N/A
12
+29%
(5)
N/A
(9)
-92%
(13)
-42%
(9)
+26%
(3)
+66%
(5)
-70%
(4)
+23%
9
N/A
8
-4%
(3)
N/A
(2)
+21%
(4)
-75%
(4)
+11%
4
N/A
4
-6%
(5)
N/A
(1)
+83%
1
N/A
(3)
N/A
8
N/A
58
+599%
57
-2%
37
-35%
38
+4%
(16)
N/A
(40)
-146%
3
N/A
Free Cash Flow
Free Cash Flow
(4)
N/A
(5)
-7%
(5)
-12%
(6)
-14%
(8)
-37%
(11)
-32%
(9)
+20%
(7)
+18%
(6)
+20%
(6)
-7%
(9)
-42%
(6)
+28%
(5)
+21%
(5)
+7%
(6)
-30%
(5)
+7%
(4)
+19%
(4)
+9%
(3)
+37%
(3)
-2%
(4)
-66%
(4)
+18%
(2)
+45%
(1)
+26%
(4)
-149%
(2)
+40%
0
N/A
3
+1 747%
5
+38%
53
+1 026%
83
+57%
64
-22%
60
-6%
40
-33%
24
-40%
23
-6%

See Also

Discover More